Australia has become the first country outside of the United States to approve the use of the drug pegcetacoplan (SYFOVRE) to slow down the progression of geographic atrophy.

Astellas Pharma seeks Japanese conditional approval of avacincaptad pegol intravitreal solution to treat geographic atrophy: Tokyo Thursday, February 6, 2025, 09:00 Hrs [IST] Aste ...

This marks the first approved treatment for ... It is a progressive and irreversible disease caused by the growth of lesions, which destroy the retinal cells responsible for vision.

SYFOVRE is the first and only approved treatment for ... 1 It is a progressive and irreversible disease caused by the growth of lesions, which destroy the retinal cells responsible for vision.

In this CE activity, experts in the field will assess how advances in imaging and new therapies for the management of geographic atrophy ... for the treatment and management of retinal vein ...

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has unveiled encouraging preliminary data from the Phase 1 portion of its OCU410 ArMaDa clinical trial, aimed at treating geographic atrophy (GA ...

Retinal degeneration encompasses a range of conditions that lead to the progressive loss of photoreceptor ... effects of VN found that while retinal atrophy developed in treated patients, the ...